Several studies have reported that serum or urinary levels of IL-17 are significantly elevated in patients with rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and autoimmune hepatitis (48–51). Here, IL17A is linked to multiple sclerosis.